PL334136A1 - Method of obtaining enantiomerically enriched methyl threophenidate - Google Patents

Method of obtaining enantiomerically enriched methyl threophenidate

Info

Publication number
PL334136A1
PL334136A1 PL97334136A PL33413697A PL334136A1 PL 334136 A1 PL334136 A1 PL 334136A1 PL 97334136 A PL97334136 A PL 97334136A PL 33413697 A PL33413697 A PL 33413697A PL 334136 A1 PL334136 A1 PL 334136A1
Authority
PL
Poland
Prior art keywords
threophenidate
enantiomerically enriched
obtaining enantiomerically
enriched methyl
methyl
Prior art date
Application number
PL97334136A
Other languages
English (en)
Inventor
Susan Faulconbridge
Hooshang Shahriari Zavareh
Graham Robert Evans
Marianne Langston
Original Assignee
Medeva Europ Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9625972.6A external-priority patent/GB9625972D0/en
Priority claimed from GBGB9712298.0A external-priority patent/GB9712298D0/en
Application filed by Medeva Europ Ltd filed Critical Medeva Europ Ltd
Publication of PL334136A1 publication Critical patent/PL334136A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL97334136A 1996-12-13 1997-12-11 Method of obtaining enantiomerically enriched methyl threophenidate PL334136A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9625972.6A GB9625972D0 (en) 1996-12-13 1996-12-13 Bioresolution
GBGB9712298.0A GB9712298D0 (en) 1997-06-12 1997-06-12 Crystallisation
PCT/GB1997/003418 WO1998025902A1 (en) 1996-12-13 1997-12-11 The preparation of enantiomerically-enriched threo-methylphenidate

Publications (1)

Publication Number Publication Date
PL334136A1 true PL334136A1 (en) 2000-02-14

Family

ID=26310627

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97334136A PL334136A1 (en) 1996-12-13 1997-12-11 Method of obtaining enantiomerically enriched methyl threophenidate

Country Status (9)

Country Link
EP (1) EP0948484A1 (cs)
JP (1) JP2001506621A (cs)
AU (1) AU7847098A (cs)
CA (1) CA2272373A1 (cs)
CZ (1) CZ206299A3 (cs)
HU (1) HUP0001604A3 (cs)
NO (1) NO992875L (cs)
PL (1) PL334136A1 (cs)
WO (1) WO1998025902A1 (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US6486177B2 (en) 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US6962997B1 (en) 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
US6100401A (en) * 1998-04-20 2000-08-08 Novartris Ag Process for preparing the d-threo isomer of methylphenidate hydrochloride
US6162919A (en) * 1998-12-03 2000-12-19 Novartis Ag Process for preparing the d-threo isomer of methylphenidate hydrochloride
US6395752B1 (en) * 1999-03-04 2002-05-28 Pharmaquest Limited Method of treating depression using 1-threo-methylphenidate
US6127385A (en) * 1999-03-04 2000-10-03 Pharmaquest Limited Method of treating depression using l-threo-methylphenidate
US6025502A (en) * 1999-03-19 2000-02-15 The Trustees Of The University Of Pennsylvania Enantopselective synthesis of methyl phenidate
US6221883B1 (en) * 2000-04-12 2001-04-24 Ross Baldessarini Method of dopamine inhibition using l-threo-methylphenidate
EP1163907B1 (en) * 2000-06-17 2006-04-12 Pharmaquest Limited Use of l-threo-methylphenidate for the manufacture of a medicament for the treatment of depression
WO2004080959A2 (en) * 2003-03-07 2004-09-23 Isp Investments Inc. Process for the preparation of dexmethylphenidate hydrochloride
US7897777B2 (en) 2007-01-05 2011-03-01 Archimica, Inc. Process of enantiomeric resolution of D,L-(±)-threo-methylphenidate
US8552030B2 (en) 2009-05-07 2013-10-08 Malladi Drugs & Pharmaceuticals Ltd. Process for the preparation of d-threo-ritalinic acid hydrochloride by resolution of dl-threo-ritalinic acid using chiral carboxylic acid
PH12013501257A1 (en) 2010-12-17 2022-03-30 Rhodes Tech Low-temperature synthesis of methylphenidate hydrochloride
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9028868B2 (en) 2011-03-23 2015-05-12 Ironshore Pharmaceuticals & Development, Inc. Methods and compositions for treatment of attention deficit disorder
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9233924B2 (en) 2014-03-11 2016-01-12 Ampac Fine Chemicals Llc Methods for preparing D-threo methylphenidate using diazomethane, and compositions thereof
US10081597B2 (en) 2014-06-27 2018-09-25 Embio Limited Process for preparation of dexmethylphenidate hydrochloride

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02190195A (ja) * 1989-01-19 1990-07-26 Rikagaku Kenkyusho 光学活性プロピオン酸エステル類化合物の製法
JPH02273196A (ja) * 1989-03-08 1990-11-07 Wisconsin Alumni Res Found ラセミ化合物の生体触媒分割のエナンチオ選択性の改良法
JP3431204B2 (ja) * 1993-04-22 2003-07-28 塩野義製薬株式会社 ノルボルナン型エステル・ヒドロラーゼ
BE1007297A3 (nl) * 1993-07-19 1995-05-09 Dsm Nv Werkwijze voor de bereiding van optisch aktieve alcoholen en esters, en alcoholen en esters toegepast en bereid in dergelijke werkwijzen.
DE4420751A1 (de) * 1994-06-15 1995-12-21 Basf Ag Verfahren zur Herstellung von enantiomerenreinen Lactamen

Also Published As

Publication number Publication date
NO992875D0 (no) 1999-06-11
CZ206299A3 (cs) 1999-09-15
NO992875L (no) 1999-06-14
AU7847098A (en) 1998-07-03
HUP0001604A2 (hu) 2000-10-28
WO1998025902A1 (en) 1998-06-18
EP0948484A1 (en) 1999-10-13
CA2272373A1 (en) 1998-06-18
HUP0001604A3 (en) 2003-03-28
JP2001506621A (ja) 2001-05-22

Similar Documents

Publication Publication Date Title
PL334136A1 (en) Method of obtaining enantiomerically enriched methyl threophenidate
PL323545A1 (en) Method of obtaining l-lysine
PL320324A1 (en) Method of obtaining l-lysine
PL323546A1 (en) Method of obtaining l-lysine
PL318452A1 (en) Method of obtaining peroxyperfluoropolyoxyalkylenes
PL330400A1 (en) Method of obtaining azacyclohexapeptides
PL320699A1 (en) Method of obtaining cephotaxime
PL335163A1 (en) Method of obtaining substituted thiazolydinodione
PL335074A1 (en) Method of obtaining eprosartane
PL332077A1 (en) Method of obtaining omepraole
PL335075A1 (en) Method of obtaining eprosartane
PL337647A1 (en) Method of obtaining enantiomerically enriched n-derivatised lactams
PL313419A1 (en) Method of obtaining beta-naphtole
PL334901A1 (en) Method of obtaining benzothiazolones
PL339188A1 (en) Method of obtaining oxaphosphorin-2-amines
PL333977A1 (en) Method of obtaining benzisothiazolyn-3-ones
PL341358A1 (en) Method of obtaining paroxetin chlorhydride
PL340915A1 (en) Method of obtaining azacycloalkylalkanoyl pseudotetrapeptides
PL317788A1 (en) Method of obtaining 3-isocyanate-propylsilane
PL332075A1 (en) Method of obtaining nizathidine
PL301929A1 (en) Method of obtaining epichlorohydine
PL341302A1 (en) Method of obtaining chlorobenzoxazoles
PL336266A1 (en) Method of obtaining epsilon-caprolactams
PL340497A1 (en) Method of obtaining formylimidazoles
GB9726186D0 (en) Method of moulding